Australia’s MGC Pharmaceuticals has announced a definitive supply agreement that will see its first epilepsy medicine in the hands of Australian patients. The company has inked a deal with Australian pharmaceutical distributor HL Pharma to bring MGC’s cannabidiol based CannEpil to the land down … Read More
The post MGC Pharma’s CannEpil Could Be Available In Australia Next Year appeared first on Dagga Magazine.